Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 11, Novembre 2011
Page(s) 973 - 978
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20112711013
Publié en ligne 30 novembre 2011
  1. Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999 ; 93 : 3167–3215. [PubMed]
  2. Qiu JJ, Lu X, Zeisig BB, et al. Leukemic transformation by the APL fusion protein PRKAR1A-RARalpha critically depends on recruitment of RXR{alpha}. Blood 2010 ; 115 : 643–652. [CrossRef] [PubMed]
  3. Nasr R, Lallemand-Breitenbach V, Zhu J, et al. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Clin Cancer Res 2009 ; 15 : 6321–6326. [CrossRef] [PubMed]
  4. Germain P, Chambon P, Eichele G, et al. International union of pharmacology. LXIII. retinoid X receptors. Pharmacol Rev 2006 ; 58 : 760–772. [CrossRef] [PubMed]
  5. Defacque H, Commes T, Legouffe E, et al. Expression of retinoid X receptor alpha is increased upon monocytic cell differentiation. Biochem Biophys Res Commun 1996 ; 220 : 315–322. [CrossRef] [PubMed]
  6. Germain P, Iyer J, Zechel C, Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 2002 ; 415 : 187–192. [CrossRef] [PubMed]
  7. Altucci L, Rossin A, Hirsch O, et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res 2005 ; 65 : 8754–8765. [CrossRef] [PubMed]
  8. Benoit G, Altucci L, Flexor M, et al. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J 1999 ; 18 : 7011–7018. [CrossRef] [PubMed]
  9. KamashevD, Vitoux D, De Thé H. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. J Exp Med 2004 ; 199 : 1163–1174. [CrossRef] [PubMed]
  10. Gaillard E, Bruck N, Brelivet Y, et al. Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. Proc Natl Acad Sci USA 2006 ; 103 : 9548–9553. [CrossRef]
  11. Adam-Stitah S, Penna L, Chambon P, Rochette-Egly C. Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. J Biol Chem 1999 ; 274 : 18932–18941. [CrossRef] [PubMed]
  12. Bastien J, Adam-Stitah S, Plassat JL, et al. The phosphorylation site located in the A region of retinoic X receptor alpha is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells. J Biol Chem 2002 ; 277 : 28683–28689. [CrossRef] [PubMed]
  13. Mann KK, Padovani AM, Guo Q, et al. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation. J Clin Invest 2005 ; 115 : 2924–2933. [CrossRef] [PubMed]
  14. Bruck N, Bastien J, Bour G, et al. Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell Signal 2005 ; 17 : 1229–1239. [CrossRef] [PubMed]
  15. Tarrade A, Bastien J, Bruck N, et al. Retinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha. Oncogene 2005 ; 24 : 2277–2288. [CrossRef] [PubMed]
  16. Zhao WX, Tian M, Zhao BX, et al. Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha. Mol Endocrinol 2007 ; 21 : 2877–2889. [CrossRef] [PubMed]
  17. Choi SJ, Chung SS, Rho EJ, et al. Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J Biol Chem 2006 ; 281 : 30669–30677. [CrossRef] [PubMed]
  18. Shimizu M, Takai K, Moriwaki H. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Cancer Sci 2009 ; 100 : 369–374. [CrossRef] [PubMed]
  19. Minucci S, Maccarana M, Cioce M, et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell 2000 ; 5 : 811–820. [CrossRef] [PubMed]
  20. Sternsdorf T, Phan VT, Maunakea ML, et al. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell 2006 ; 9 : 81–94. [CrossRef] [PubMed]
  21. Martens JH, Brinkman AB, Simmer F, et al. PML-RARalpha/RXR alters the epigenetic landscape in acute promyelocytic leukemia. Cancer Cell 2010 ; 17 : 173–185. [CrossRef] [PubMed]
  22. Perez A, Kastner P, Sethi S, et al. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 1993 ; 12 : 3171–3182. [PubMed]
  23. Hu Q, Kwon YS, Nunez E, et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA 2008 ; 105 : 19199–19204. [CrossRef]
  24. Zhu J, Nasr R, Pérès L, et al. RXR is an essential component of the oncogenic PML/RARA complex in vivo. Cancer Cell 2007 ; 12 : 23–35. [CrossRef] [PubMed]
  25. Zhu J, Gianni M, Kopf E, et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc Natl Acad Sci USA 1999 ; 96 : 14807–14812. [CrossRef]
  26. Zeisig BB, Kwok C, Zelent A, et al. Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation. Cancer Cell 2007 ; 12 : 36–51. [CrossRef] [PubMed]
  27. Taschner S, Koesters C, Platzer B, et al. Down-regulation of RXRalpha expression is essential for neutrophil development from granulocyte/monocyte progenitors. Blood 2007 ; 109 : 971–979. [CrossRef] [PubMed]
  28. Guillemin MC, Raffoux E, Vitoux D, et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med 2002 ; 196 : 1373–1380. [CrossRef] [PubMed]
  29. Sukhai MA, Thomas M, Xuan Y, et al. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia. Oncogene 2008 ; 27 : 4666–4677. [CrossRef] [PubMed]
  30. Nasr R, Guillemin MC, Ferhi O, et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med 2008 ; 14 : 1333–1342. [CrossRef] [PubMed]
  31. Yokoyama A, Somervaille TC, Smith KS, et al. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005 ; 123 : 207–218. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.